Omeprazolo Eg Stada (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Eg Stada, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat gastro‑reflux related conditions in adults and children.

GNH USA supplies Omeprazolo Eg Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazolo Eg Stada is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.

Adverse reactions to omeprazole vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort. - Diarrhea: loose, watery stools. - Nausea: feeling of stomach upset. - Abdominal pain: cramping or discomfort in the stomach area. - Flatulence: excess gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, dizziness, or trouble breathing. - Clostridioides difficile infection: persistent diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Fracture risk: increased likelihood of hip, wrist, or spine fractures with long‑term use. - Liver enzyme elevation: signs of liver dysfunction detected in blood tests. - Acute interstitial nephritis: kidney inflammation presenting with fever, rash, and urinary changes.

When using Omeprazolo Eg Stada, consider the following safety measures: - Assess renal function: adjust use if significant impairment exists. - Evaluate hepatic function: use with caution in patients with liver disease. - Review long‑term therapy: periodic reassessment is advised for chronic users. - Monitor for vitamin B12 deficiency: prolonged acid suppression may affect absorption. - Pregnancy and lactation: weigh benefits against potential risks; consult a healthcare professional. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture.

Omeprazolo Eg Stada may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: omeprazole reduces its antiplatelet activation. - Atazanavir: decreased absorption due to higher gastric pH. - HIV protease inhibitors (e.g., nelfinavir): lowered plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Phenytoin: may lower phenytoin levels. - Methotrexate: reduced renal clearance can raise toxicity risk. - Digoxin: possible increase in serum concentrations. - Iron supplements: diminished absorption when taken concurrently.